Matsuoka, K.
2743  results:
Search for persons X
?
2

P1187 Persistence of Advanced Therapies in Patients with In..:

Matsuoka, K ; Kawamura, S ; Zhang, Y...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i2114-i2114 , 2024
 
?
3

P678 Long-term efficacy, safety and health-related quality ..:

Feagan Senior Scientific Officer, B G ; Matsuoka, K ; Rogler, G...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1288-i1289 , 2024
 
?
5

P687 Ozanimod as a once-daily oral therapy for Japanese pat..:

Matsuoka, K ; Nakase, H ; Fujii, T...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1305-i1306 , 2024
 
?
6

P932 Corticosteroid-sparing effect of mirikizumab for the t..:

Laharie, D ; Siegel, C ; Dulai, P...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1697-i1698 , 2024
 
?
7

Corrigendum to "Measured and projected beam backgrounds in ..:

Natochii, A. ; Browder, T.E. ; Cao, L....
Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment.  1060 (2024)  - p. 169037 , 2024
 
?
9

P1189 Clinical features and surgical necessity rate of fist..:

Takatsu, N ; Yamamoto, T ; Nakase, H...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i2118-i2120 , 2024
 
?
10

OC.07.3: CORTICOSTEROID-SPARING EFFECT IN PATIENTS WITH MOD..:

Laharie, D. ; Siegel, C.A. ; Samaan, K....
Digestive and Liver Disease.  56 (2024)  - p. S163-S164 , 2024
 
?
11

P283 Efficacy and safety of etrasimod in patients with mode..:

Takeuchi, K ; Hisamatsu, T ; Nakase, H...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i651-i652 , 2024
 
?
12

P1085 Machine learning to predict the efficacy of ustekinum..:

Morikubo, H ; Tojima, R ; Maeda, T...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1951-i1952 , 2024
 
?
13

OP14 Effect of mirikizumab on clinical and endoscopic outco..:

Hart, A ; Martín-Arranz, M D ; Laharie, D...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i27-i28 , 2024
 
?
14

P760 Post-marketing surveillance of tofacitinib in patients..:

Matsuoka, K ; Motoya, S ; Yamamoto, T...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1417-i1419 , 2024
 
?
15

P1009 Efficacy and safety of 4 years of continuous ozanimod..:

D'Haens, G ; Sands, B E ; Ferrante, M...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1823-i1824 , 2024
 
1-15